Basket Study for Oligo-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
- Status
- COMPLETED
- Phase
- PHASE1
IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria
- Status
- COMPLETED
- Phase
- N/A
A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population
- Status
- COMPLETED
- Phase
- PHASE1
Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Baxdrostat Bioavailability and Bioequivalence Study
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat
- Status
- COMPLETED
- Phase
- PHASE1
EGFR_IUO 3.20 Clinical Study Protocol
- Status
- WITHDRAWN
- Phase
- NA
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
- Status
- COMPLETED
- Phase
- N/A
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..
- Status
- COMPLETED
- Phase
- PHASE1
Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics
- Status
- COMPLETED
- Phase
- N/A
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
- Status
- RECRUITING
- Phase
- NA
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3